Company page

Medite Cancer Diagnostics Inc

Medite Cancer Diagnostics Inc (ticker: MDIT) is a public company operating in the American market, specializing in cancer diagnostics. With a market capitalization of approximately $8.62 billion, Medite focuses on developing innovative solutions for cancer detection and management. The company aims to improve patient outcomes through advanced diagnostic technologies.

profileMDIT:OTCAI content: aiUpdated June 24, 2026/company/medite-cancer-diagnostics-inc/c-pinr7btm
Medite Cancer Diagnostics Inc logo
Ticker
MDIT:OTC
Asset type
Stock
Market cap
$8,620
Sector
Health Technology
Industry
Medical Specialties
Exchange
OTC
Currency
USD